PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
PACS Group, Inc.NYSE: PACS
Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026
Capital expenditures growth accelerates
Q2 FY2026 capital expenditures of $26.53M (cash outflow) rose 42.8% year over year, ahead of the -36.6% change in trailing-twelve-month capital expenditures. Sequentially, it rose 21.5% from the prior quarter. Over 3 fiscal years it compounded at +66.4% a year.
Context
- Capital expenditures amounted to 2.0% of revenue in FY2025, down 6.6 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +42.8% holds above the trailing-twelve-month pace of -36.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (105.41M) USD
- Year-over-year change
- +69.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (105.41M) | +69.9% |
| FY2024 | 2024-12-31 | (349.81M) | -664.1% |
| FY2023 | 2023-12-31 | (45.78M) | -100.3% |
| FY2022 | 2022-12-31 | (22.86M) | +81.6% |
| FY2021 | 2021-12-31 | (124.09M) | — |
Capital Expenditures vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's LTM Jun 2026 capital expenditures of $117.47M is the 6th largest of the 11 companies compared; the peer median is $117.69M.
- Its year-over-year change of -36.6% is the 10th highest of 11, against a peer median of +16.3%.
- Capital expenditures amounts to 2.1% of revenue for PACS, versus a peer median of 2.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.13B | +10.4% | +4.0% | 6.6% | |
| LTM Jun 2026 | $799.1M | +19.9% | +8.0% | 12.9% | |
| LTM Mar 2026 | $326M | -7.4% | -6.9% | 1.5% | |
| LTM Sep 2026 | $217.71M | +15.7% | +0.8% | 7.4% | |
| LTM Jun 2026 | $189.34M | +1.7% | +30.3% | 3.5% | |
| LTM Jun 2026 | $117.47M | -36.6% | +66.4% | 2.1% | |
| LTM Sep 2026 | $46.05M | +34.6% | +6.5% | 2.9% | |
| LTM Mar 2026 | $18.77M | +113.1% | +15.8% | 1.8% | |
| LTM Mar 2026 | $11.39M | +16.8% | -45.3% | 1.2% | |
| LTM Jun 2026 | $7.84M | -70.2% | -23.0% | 0.5% | |
| LTM Mar 2026 | $3.66M | +124.1% | -44.3% | 0.4% | |
| Peer median (excluding PACS) | $117.69M | +16.3% | +2.4% | 2.4% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 47.95M | 150.5M | 112.87M | 55.76M | 191.46M |
| Depreciation & Amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| Deferred Income Tax | 7.83M | (1.92M) | (9.92M) | (44.48M) | (17.73M) |
| Stock-Based Compensation | 0 | 0 | 0 | 115.54M | 54.07M |
| Change in Working Capital | (4.36M) | (94.29M) | (94.66M) | 158.22M | 72.71M |
| Accounts Receivables | (40.09M) | (114.62M) | (179.94M) | (116.46M) | 14.43M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 30.78M | 32.81M | 33.37M | 33.4M | 14.86M |
| Other Working Capital | 4.95M | (12.48M) | 51.91M | 241.27M | 43.43M |
| Other Non-Cash Items | (975K) | 16.02M | 29.78M | 41.5M | 48.05M |
| Operating Cash Flow | 57.6M | 92.62M | 63.7M | 367.34M | 404.22M |
| Capital Expenditures | (124.09M) | (22.86M) | (45.78M) | (349.81M) | (105.41M) |
| Acquisitions (Net) | (79.68M) | (55.37M) | (127.02M) | (32.89M) | (143M) |
| Purchases of Investments | (15.71M) | 0 | (2.6M) | (90.87M) | (21.21M) |
| Sales of Investments | 877K | 0 | 1.86M | 25.87M | 5.59M |
| Other Investing Activities | 0 | 2.92M | 750K | 5.02M | 0 |
| Investing Cash Flow | (218.6M) | (75.32M) | (172.79M) | (442.68M) | (264.03M) |
| Debt Repayment | 235.85M | 69.38M | 209.4M | (325.15M) | (60.22M) |
| Common Stock Issued | 0 | 0 | 0 | 509.44M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (53.8M) | (60.28M) | (80.39M) | (33.72M) | 0 |
| Other Financing Activities | 0 | 3.25M | 587K | (33.1M) | (8.77M) |
| Financing Cash Flow | 182.05M | 12.35M | 129.59M | 117.48M | (68.99M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 21.05M | 29.64M | 20.5M | 42.14M | 71.21M |
| Free Cash Flow | (66.49M) | 69.75M | 17.92M | 17.53M | 298.82M |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.